Smoke Inhalation clinical trials at University of California Health
1 research study open to eligible people
open to eligible people ages 18-50
This study compares the health effects of dermal and inhalational exposure to thirdhand cigarette smoke to those of inhalational exposure to secondhand cigarette smoke in healthy, adult nonsmokers. Our hypothesis is that dermal exposure increases exposure to the tobacco specific carcinogen, NNK and may affect both endothelial function and epidermal integrity.
Our lead scientists for Smoke Inhalation research studies include Suzaynn F Schick, PhD.